Showing results (1581-1590 of 1,781) with videos related to

Sort By:
Pageof 179
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
Circulation|December 26, 2024
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi ApproachNicholas W S Chew, Anurag Mehta, Rachel Sze Jen Goh, et al.
Zhonghua Nei Ke Za Zhi|December 1, 2020
[Efficacy and safety of Changsulin Ⅲ multicenter, randomized, open-label, parallel, controlled clinical trial]T T Zhang, X M Liu, B Y Shi, et al.
Nature Communications|May 18, 2021
Observation of topological superconductivity in a stoichiometric transition metal dichalcogenide 2M-WS2Y W Li, H J Zheng, Y Q Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal JunctionMojun Zhu, Chunhua Chen, Nathan R Foster, et al.
The British Journal of Surgery|April 5, 2020
Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasionX-P Zhang, K Wang, Y-Z Gao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2025
Enhanced risk stratification for stage II colorectal cancer using deep learning-based CT classifier and pathological markers to optimize adjuvant therapy decisionY Q Huang, X B Chen, Y F Cui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 2, 2025
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical PracticeLuis Antonio Diaz, Veeral Ajmera, Juan Pablo Arab, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 23, 2017
[Application of pegylated recombinant human granulocyte colony-stimulating factor to prevent chemotherapy-induced neutropenia in patients with lymphoma: a prospective, multicenter, open-label clinical trial]H Q Huang, B Bai, Y H Gao, et al.
The New England Journal of Medicine|November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian CancerRobert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Pageof 179